A historic shift in Canadian drug policy has happened, as the regulators allow the use of psilocybin hallucinogens for therapeutic applications. Previously, these substances were heavily restricted, but a increasing body of research suggests they potentially offer relief for emotional conditions like depression. This change represents a major step